These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 9305902

  • 1. Complete rescue of lethal albino c14CoS mice by null mutation of 4-hydroxyphenylpyruvate dioxygenase and induction of apoptosis of hepatocytes in these mice by in vivo retrieval of the tyrosine catabolic pathway.
    Endo F, Kubo S, Awata H, Kiwaki K, Katoh H, Kanegae Y, Saito I, Miyazaki J, Yamamoto T, Jakobs C, Hattori S, Matsuda I.
    J Biol Chem; 1997 Sep 26; 272(39):24426-32. PubMed ID: 9305902
    [Abstract] [Full Text] [Related]

  • 2. A mouse model of renal tubular injury of tyrosinemia type 1: development of de Toni Fanconi syndrome and apoptosis of renal tubular cells in Fah/Hpd double mutant mice.
    Sun MS, Hattori S, Kubo S, Awata H, Matsuda I, Endo F.
    J Am Soc Nephrol; 2000 Feb 26; 11(2):291-300. PubMed ID: 10665936
    [Abstract] [Full Text] [Related]

  • 3. Tyrosinaemia type I and apoptosis of hepatocytes and renal tubular cells.
    Endo F, Sun MS.
    J Inherit Metab Dis; 2002 May 26; 25(3):227-34. PubMed ID: 12137232
    [Abstract] [Full Text] [Related]

  • 4. Animal models of tyrosinemia.
    Nakamura K, Tanaka Y, Mitsubuchi H, Endo F.
    J Nutr; 2007 Jun 26; 137(6 Suppl 1):1556S-1560S; discussion 1573S-1575S. PubMed ID: 17513424
    [Abstract] [Full Text] [Related]

  • 5. Rescue of mice homozygous for lethal albino deletions: implications for an animal model for the human liver disease tyrosinemia type 1.
    Kelsey G, Ruppert S, Beermann F, Grund C, Tanguay RM, Schütz G.
    Genes Dev; 1993 Dec 26; 7(12A):2285-97. PubMed ID: 8253377
    [Abstract] [Full Text] [Related]

  • 6. Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1.
    Aponte JL, Sega GA, Hauser LJ, Dhar MS, Withrow CM, Carpenter DA, Rinchik EM, Culiat CT, Johnson DK.
    Proc Natl Acad Sci U S A; 2001 Jan 16; 98(2):641-5. PubMed ID: 11209059
    [Abstract] [Full Text] [Related]

  • 7. Hepatocyte injury in tyrosinemia type 1 is induced by fumarylacetoacetate and is inhibited by caspase inhibitors.
    Kubo S, Sun M, Miyahara M, Umeyama K, Urakami K, Yamamoto T, Jakobs C, Matsuda I, Endo F.
    Proc Natl Acad Sci U S A; 1998 Aug 04; 95(16):9552-7. PubMed ID: 9689118
    [Abstract] [Full Text] [Related]

  • 8. Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1.
    Ates I, Stuart C, Rathbone T, Barzi M, He G, Major AM, Shankar V, Lyman RA, Angner SS, Mackay TFC, Srinivasan S, Farris AB, Bissig KD, Cottle RN.
    Hepatol Commun; 2024 May 01; 8(5):. PubMed ID: 38668730
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tissue-specific FAH deficiency alters sleep-wake patterns and results in chronic tyrosinemia in mice.
    Yang S, Siepka SM, Cox KH, Kumar V, de Groot M, Chelliah Y, Chen J, Tu B, Takahashi JS.
    Proc Natl Acad Sci U S A; 2019 Oct 29; 116(44):22229-22236. PubMed ID: 31611405
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Molecular Aspects of the FAH Mutations Involved in HT1 Disease.
    Morrow G, Angileri F, Tanguay RM.
    Adv Exp Med Biol; 2017 Oct 29; 959():25-48. PubMed ID: 28755182
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview.
    St-Louis M, Tanguay RM.
    Hum Mutat; 1997 Oct 29; 9(4):291-9. PubMed ID: 9101289
    [Abstract] [Full Text] [Related]

  • 17. Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype.
    Neuckermans J, Lequeue S, Claes P, Heymans A, Hughes JH, Colemonts-Vroninks H, Marcélis L, Casimir G, Goyens P, Martens GA, Gallagher JA, Vanhaecke T, Bou-Gharios G, De Kock J.
    Genes (Basel); 2023 Mar 11; 14(3):. PubMed ID: 36980965
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice.
    Grompe M, al-Dhalimy M, Finegold M, Ou CN, Burlingame T, Kennaway NG, Soriano P.
    Genes Dev; 1993 Dec 11; 7(12A):2298-307. PubMed ID: 8253378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.